Javascript must be enabled to continue!
Prognostic Significance of Autophagy-Relevant Gene Markers in Colorectal Cancer
View through CrossRef
BackgroundColorectal cancer (CRC) is a common malignant solid tumor with an extremely low survival rate after relapse. Previous investigations have shown that autophagy possesses a crucial function in tumors. However, there is no consensus on the value of autophagy-associated genes in predicting the prognosis of CRC patients. This work screens autophagy-related markers and signaling pathways that may participate in the development of CRC, and establishes a prognostic model of CRC based on autophagy-associated genes.MethodsGene transcripts from the TCGA database and autophagy-associated gene data from the GeneCards database were used to obtain expression levels of autophagy-associated genes, followed by Wilcox tests to screen for autophagy-related differentially expressed genes. Then, 11 key autophagy-associated genes were identified through univariate and multivariate Cox proportional hazard regression analysis and used to establish prognostic models. Additionally, immunohistochemical and CRC cell line data were used to evaluate the results of our three autophagy-associated genes EPHB2, NOL3, and SNAI1 in TCGA. Based on the multivariate Cox analysis, risk scores were calculated and used to classify samples into high-risk and low-risk groups. Kaplan-Meier survival analysis, risk profiling, and independent prognosis analysis were carried out. Receiver operating characteristic analysis was performed to estimate the specificity and sensitivity of the prognostic model. Finally, GSEA, GO, and KEGG analysis were performed to identify the relevant signaling pathways.ResultsA total of 301 autophagy-related genes were differentially expressed in CRC. The areas under the 1-year, 3-year, and 5-year receiver operating characteristic curves of the autophagy-based prognostic model for CRC were 0.764, 0.751, and 0.729, respectively. GSEA analysis of the model showed significant enrichment in several tumor-relevant pathways and cellular protective biological processes. The expression of EPHB2, IL-13, MAP2, RPN2, and TRAF5 was correlated with microsatellite instability (MSI), while the expression of IL-13, RPN2, and TRAF5 was related to tumor mutation burden (TMB). GO analysis showed that the 11 target autophagy genes were chiefly enriched in mRNA processing, RNA splicing, and regulation of the mRNA metabolic process. KEGG analysis showed enrichment mainly in spliceosomes. We constructed a prognostic risk assessment model based on 11 autophagy-related genes in CRC.ConclusionA prognostic risk assessment model based on 11 autophagy-associated genes was constructed in CRC. The new model suggests directions and ideas for evaluating prognosis and provides guidance to choose better treatment strategies for CRC.
Frontiers Media SA
Title: Prognostic Significance of Autophagy-Relevant Gene Markers in Colorectal Cancer
Description:
BackgroundColorectal cancer (CRC) is a common malignant solid tumor with an extremely low survival rate after relapse.
Previous investigations have shown that autophagy possesses a crucial function in tumors.
However, there is no consensus on the value of autophagy-associated genes in predicting the prognosis of CRC patients.
This work screens autophagy-related markers and signaling pathways that may participate in the development of CRC, and establishes a prognostic model of CRC based on autophagy-associated genes.
MethodsGene transcripts from the TCGA database and autophagy-associated gene data from the GeneCards database were used to obtain expression levels of autophagy-associated genes, followed by Wilcox tests to screen for autophagy-related differentially expressed genes.
Then, 11 key autophagy-associated genes were identified through univariate and multivariate Cox proportional hazard regression analysis and used to establish prognostic models.
Additionally, immunohistochemical and CRC cell line data were used to evaluate the results of our three autophagy-associated genes EPHB2, NOL3, and SNAI1 in TCGA.
Based on the multivariate Cox analysis, risk scores were calculated and used to classify samples into high-risk and low-risk groups.
Kaplan-Meier survival analysis, risk profiling, and independent prognosis analysis were carried out.
Receiver operating characteristic analysis was performed to estimate the specificity and sensitivity of the prognostic model.
Finally, GSEA, GO, and KEGG analysis were performed to identify the relevant signaling pathways.
ResultsA total of 301 autophagy-related genes were differentially expressed in CRC.
The areas under the 1-year, 3-year, and 5-year receiver operating characteristic curves of the autophagy-based prognostic model for CRC were 0.
764, 0.
751, and 0.
729, respectively.
GSEA analysis of the model showed significant enrichment in several tumor-relevant pathways and cellular protective biological processes.
The expression of EPHB2, IL-13, MAP2, RPN2, and TRAF5 was correlated with microsatellite instability (MSI), while the expression of IL-13, RPN2, and TRAF5 was related to tumor mutation burden (TMB).
GO analysis showed that the 11 target autophagy genes were chiefly enriched in mRNA processing, RNA splicing, and regulation of the mRNA metabolic process.
KEGG analysis showed enrichment mainly in spliceosomes.
We constructed a prognostic risk assessment model based on 11 autophagy-related genes in CRC.
ConclusionA prognostic risk assessment model based on 11 autophagy-associated genes was constructed in CRC.
The new model suggests directions and ideas for evaluating prognosis and provides guidance to choose better treatment strategies for CRC.
Related Results
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
Data from Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion
Data from Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion
<div>Abstract<p>Autophagy is a mechanism by which cells degrade cellular material to provide nutrients and energy for survival during stress. The autophagy is thought t...
Data from Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion
Data from Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion
<div>Abstract<p>Autophagy is a mechanism by which cells degrade cellular material to provide nutrients and energy for survival during stress. The autophagy is thought t...
Abstract 1688: Autophagy inhibition enhances the antitumor effects of combretastatin A4 phosphate (CA4P).
Abstract 1688: Autophagy inhibition enhances the antitumor effects of combretastatin A4 phosphate (CA4P).
Abstract
Vascular disruptive agents such as CA4P cause an acute shutdown of the tumor vasculature resulting in metabolic stress and central tumor necrosis. However, ...
Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
Abstract
Considering that a tumor promoting role for GSK3 has been suggested in pancreatic cancer (PC) cells and that GSK3 inhibitors are currently under clinical tr...
Eficacia, seguridad y eficiencia de la radioterapia corporal estereotáctica aplicada con marcadores de referencia en oncología
Eficacia, seguridad y eficiencia de la radioterapia corporal estereotáctica aplicada con marcadores de referencia en oncología
Introduction
Stereotactic body radiotherapy (SBRT) is a technology that involves delivering high doses of radiation, in few sessios and with high precision, to a specific tumor loc...
Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance
Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance
Abstract
OBJECTIVE:
Colorectal cancer is a cancer with high prevalence and mortality rates worldwide, treated with surger...
Abstract 2271: Autophagy induction by low dose cisplatin: The role of p53 in autophagy
Abstract 2271: Autophagy induction by low dose cisplatin: The role of p53 in autophagy
Abstract
Cisplatin has been mainly used for lung-cancer. However, cisplatin has many side effects, so the usage of cisplatin has a limitation. Recently, autophagy ha...

